{
  "question_stem": {
    "en": "A 24-year-old woman comes to the office due to 3 weeks of worsening throat pain and difficulty swallowing. She has no chronic medical problems but has had recurrent vulvovaginal candidiasis and bacterial folliculitis over the past year. The patient has also had an unintentional weight loss of 4.5-kg (10-lb) over the past 3 months. She is an exchange student from Senegal. Physical examination shows generalized lymphadenopathy and oropharyngeal thrush. Upper endoscopy confirms Candida esophagitis. HIV antigen/antibody immunoassay returns positive. Further testing shows a CD4 count of 180/mm³ but there is no detectable plasma HIV-1 RNA.",
    "zh": "一名24岁女性因3周来加重的咽喉疼痛和吞咽困难就诊。她没有慢性病史，但在过去一年中反复出现外阴阴道念珠菌病和细菌性毛囊炎。患者在过去3个月中也出现4.5公斤（10磅）的非意向性体重减轻。她是来自塞内加尔的交换生。体格检查显示全身淋巴结肿大和口咽鹅口疮。上消化内镜检查证实食管念珠菌病。HIV抗原/抗体免疫测定结果呈阳性。进一步检测显示CD4计数为180/mm³，但未检测到血浆HIV-1 RNA。"
  },
  "question": {
    "en": "Which of the following best explains the observed laboratory findings in this patient?",
    "zh": "以下哪项最能解释该患者观察到的实验室检查结果？"
  },
  "options": {
    "A": {
      "en": "False-positive serology from cross-reactive antibodies",
      "zh": "交叉反应抗体引起的假阳性血清学结果"
    },
    "B": {
      "en": "Homozygous CCR5 deletion",
      "zh": "CCR5纯合子缺失"
    },
    "C": {
      "en": "Infection with CXCR4 tropic strain",
      "zh": "感染CXCR4亲嗜性毒株"
    },
    "D": {
      "en": "Infection with HIV-2",
      "zh": "感染HIV-2"
    },
    "E": {
      "en": "Window period of HIV infection",
      "zh": "HIV感染的窗口期"
    }
  },
  "correct_answer": "D",
  "explanation": {
    "en": "This patient's opportunistic infection (oropharyngeal/esophageal candidiasis), positive HIV immunoassay testing, and low CD4 count suggest a diagnosis of AIDS. However, she has no detectable HIV-1 RNA in her bloodstream. Although HIV-1 causes most cases of AIDS worldwide (and nearly all cases in the United States), AIDS can also be due to infection with HIV-2, which is endemic to West Africa (eg, Senegal).\n\nPatients infected with HIV-2 have much lower levels of viremia than those infected with HIV-1. Because viremia is directly correlated with transmission risk, rate of CD4 count decline, and progression to AIDS, individuals with HIV-2 are usually less infectious and have longer asymptomatic periods than patients with HIV-1. The diagnosis of HIV-2 is often suspected when HIV test results are incongruent: most patients will have the following laboratory results:\n\n*   Positive fourth-generation HIV testing (HIV antigen/antibody test) – This test evaluates for the presence of p24 antigen and HIV-1 and HIV-2 antibodies but does not usually differentiate between HIV-1 and HIV-2.\n*   Indeterminate or negative HIV-1 confirmatory testing – HIV-1 Western blot evaluates for proteins in HIV-1 and is usually indeterminate in the setting of HIV-2 infection. Plasma HIV-1 RNA testing will be negative.\n\nConfirmation of HIV-2 infection can be made using an HIV-1/HIV-2 differentiation immunoassay. Treatment with antiretroviral therapy is required to prevent HIV-2 disease progression. However, nonnucleoside reverse transcriptase inhibitors and fusion inhibitors must be avoided because HIV-2 is intrinsically resistant to these HIV medications.\n\n(Choice A) False-positive HIV serology can be seen in the setting of cross-reacting antibodies due to pregnancy, rheumatic disease, and malignancy. Although patients with cross-reacting antibodies have negative plasma HIV RNA, they would not have low CD4 counts or an AIDS-defining defining illness (eg, esophageal thrush).\n\n(Choice B) HIV attacks host cells by binding to the host CD4 receptor and CCR5 (or CXCR4) chemokine coreceptor. Homozygous deletion to CCR5 usually prevents HIV infection because the virus is not able to enter host cells; these individuals would not typically develop low CD4 count or signs of AIDS.\n\n(Choice C) X4 strains of HIV-1 use the chemokine receptor CXCR4 as a coreceptor during viral entry into host cells. Patients who are infected with X4 strains have positive plasma HIV-1 RNA.\n\n(Choice E) The window period occurs during early HIV infection when serologic testing and antigen testing for HIV are not yet positive. This patient had positive HIV antigen/antibody testing; therefore, she is not in the window period.\n\nEducational objective:\n\nMost cases of AIDS worldwide are caused by HIV-1. However, AIDS can also be caused by infection with HIV-2, which is endemic to West Africa. HIV-2 infection is associated with lower viral loads, less risk of transmission, and a slower progression to AIDS. The diagnosis is often suspected when HIV tests are incongruent (positive screening serology but indeterminate Western blot and negative plasma HIV-1 RNA). Confirmation can be made using HIV-1/HIV-2 immunodifferentiation assay.",
    "zh": "该患者的机会性感染（口咽/食管念珠菌病）、HIV免疫测定阳性以及CD4计数低表明诊断为艾滋病。然而，她的血液中没有可检测到的HIV-1 RNA。尽管HIV-1导致了全球范围内（以及美国几乎所有）的艾滋病病例，但艾滋病也可能是由感染HIV-2引起的，HIV-2在西非（如塞内加尔）是地方性流行病。\n\n感染HIV-2的患者比感染HIV-1的患者的病毒血症水平要低得多。由于病毒血症与传播风险、CD4计数下降速度和进展为艾滋病直接相关，因此感染HIV-2的个体通常比感染HIV-1的患者传染性较低，并且无症状期更长。当HIV检测结果不一致时，通常会怀疑HIV-2的诊断：大多数患者将具有以下实验室结果：\n\n*   第四代HIV检测呈阳性（HIV抗原/抗体检测）——该检测评估p24抗原以及HIV-1和HIV-2抗体的存在，但通常无法区分HIV-1和HIV-2。\n*   HIV-1确诊检测结果不确定或阴性——HIV-1 Western blot检测HIV-1中的蛋白质，在HIV-2感染的情况下通常不确定。血浆HIV-1 RNA检测将呈阴性。\n\n可以使用HIV-1/HIV-2分化免疫测定来确认HIV-2感染。需要使用抗逆转录病毒疗法来预防HIV-2疾病进展。然而，必须避免使用非核苷类逆转录酶抑制剂和融合抑制剂，因为HIV-2对这些HIV药物具有内在耐药性。\n\n（选项A）在妊娠、风湿病和恶性肿瘤的情况下，由于交叉反应抗体，可能会出现HIV血清学假阳性。尽管具有交叉反应抗体的患者血浆HIV RNA呈阴性，但他们不会出现CD4计数低或艾滋病相关的疾病（例如，食管鹅口疮）。\n\n（选项B）HIV通过与宿主CD4受体和CCR5（或CXCR4）趋化因子辅助受体结合来攻击宿主细胞。CCR5纯合子缺失通常可防止HIV感染，因为病毒无法进入宿主细胞；这些个体通常不会发展为CD4计数低或艾滋病的体征。\n\n（选项C）HIV-1的X4毒株在病毒进入宿主细胞的过程中使用趋化因子受体CXCR4作为辅助受体。感染X4毒株的患者血浆HIV-1 RNA呈阳性。\n\n（选项E）窗口期发生在HIV感染的早期，此时HIV的血清学检测和抗原检测尚未呈阳性。该患者的HIV抗原/抗体检测呈阳性；因此，她不在窗口期。\n\n教学目标：\n\n全球范围内的大多数艾滋病病例是由HIV-1引起的。然而，艾滋病也可能是由感染HIV-2引起的，HIV-2在西非是地方性流行病。HIV-2感染与较低的病毒载量、较低的传播风险和进展为艾滋病的速度较慢有关。当HIV检测结果不一致时，通常会怀疑这种诊断（阳性筛查血清学结果但Western blot不确定，血浆HIV-1 RNA阴性）。可以使用HIV-1/HIV-2免疫分化测定进行确认。"
  },
  "summary": {
    "en": "This question tests knowledge of HIV-2 infection, its epidemiology, diagnostic findings, and differences from HIV-1. It requires understanding that HIV-2 is endemic to West Africa and can present with a positive HIV antigen/antibody test but undetectable HIV-1 RNA.\n\nTo solve this question, consider the patient's origin (Senegal), the positive HIV antigen/antibody test, the low CD4 count, and the undetectable HIV-1 RNA. Rule out other options based on their incompatibility with the clinical and laboratory findings.",
    "zh": "此题考察了对HIV-2感染、其流行病学、诊断结果以及与HIV-1差异的了解。它需要理解HIV-2在西非是地方性流行病，并且可能表现为HIV抗原/抗体检测呈阳性但HIV-1 RNA不可检测。\n\n要解决这个问题，请考虑患者的来源（塞内加尔）、HIV抗原/抗体检测呈阳性、CD4计数低以及HIV-1 RNA不可检测。根据其他选项与临床和实验室结果的不相容性，排除其他选项。"
  },
  "tags": "HIV-2; AIDS; Retrovirus; West Africa; CD4 count; Viral load; HIV testing; Opportunistic infections; Infectious disease; Immunology",
  "category": "Micro",
  "question_id": "15125",
  "has_exhibits": false,
  "exhibit_count": 0,
  "exhibit_files": [],
  "folder_path": "C:\\Datas\\usmle\\step1\\clip\\Micro 23\\15125",
  "extracted_at": "2025-11-05T14:57:33.218784",
  "extraction_config": {
    "temperature": 0.1,
    "top_k": 1,
    "prompt_strategy": "standard"
  },
  "translated_at": "2025-11-07T18:08:23.106606",
  "translation_model": "gemini-2.0-flash-lite",
  "embedding_model": "models/embedding-001",
  "embedding_dimension": 768
}